Skip to content
Home/Companies/Biotech/FairJourney Biologics

FairJourney Biologics

Biotech·Portugal·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns FairJourney Biologics?

FairJourney Biologics is a Portuguese Biotech company, currently owned by Partners Group since 2024. It changed hands in 2024, when GHO Capital sold.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
Partners Group
Most recent investor
Partners Group
Partners Group Direct Equity V · 2024 · Buyout
2 ownership periods · full history below

Key facts

HQPortugal
SectorBiotech
StatusAcquired

Ownership history

2 ownership periods

Active
Currently held by Partners Group since 2024.
GHO Capital
GHO CapitalExited 2024
2020 · 2024(4yr) · GHO Capital Fund II LP · 2019 · Buyout
Secondary · to Partners Group

GHO Capital sold FairJourney Biologics to Partners Group in 2024 after 4 years.

Partners Group
2024 · present(2yr) · Partners Group Direct Equity V · 2024 · Buyout

More from Partners Group Direct Equity V

Other portfolio companies in the same fund.

Questions

Who owns FairJourney Biologics?

FairJourney Biologics is currently owned by Partners Group, through Partners Group Direct Equity V, since 2024.

When did Partners Group acquire FairJourney Biologics?

Partners Group acquired FairJourney Biologics in 2024.

Who did FairJourney Biologics sell to?

GHO Capital sold FairJourney Biologics to Partners Group in 2024 (Secondary).

Who has owned FairJourney Biologics over time?

FairJourney Biologics has been through 2 private-equity ownership periods: GHO Capital · via GHO Capital Fund II LP · 2020–2024 · sold to Partners Group · (Secondary); Partners Group · via Partners Group Direct Equity V · since 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue